Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers

Venkat R. Katkoori(Michigan State University), Harvey L. Bumpers(Michigan State University)
Oncotarget
July 27, 2015
Cited by 29


Related Papers